San Francisco, CA—Percutaneous closure of the patent ductus arteriosus (PDA) in children using a novel device is safe and effective, according to a prospective study presented in a featured clinical ...

Abbott announced that the FDA approved a closure device for the treatment of premature babies with patent ductus arteriosus who are nonresponsive to medical management. The Amplatzer Piccolo occluder ...

One out of 10 of all babies are born premature. One in 10 babies are born premature and Irie Felkner and her twin brother, Judah Felkner, were two of them. Born 13 weeks prematurely, they were unable ...

In 2019, the U.S. Food and Drug Administration approved the first PDA occlusion device for infants as small as 700 grams, leading to rapid adoption of tcPDA in premature infants. Catheter-based ...

KUALA LUMPUR, Malaysia, June 6, 2025 /PRNewswire/ -- Pantai Hospital Kuala Lumpur (PHKL) marked a significant milestone in cardiovascular care with the successful transcatheter device occlusion of a ...

Extremely low birth weight (ELBW) infants with moderate to large patent ductus arteriosus (PDA) may benefit from transcatheter PDA closure (TCPC) in the first four weeks of life, according to research ...

A PDA requiring treatment is present in approximately 20% of premature infants 1 ABBOTT PARK, Ill., Dec. 18, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) today announced it has received U.S. Food and Drug ...

When Candace Rice went into labor around Christmas, she was 24 weeks into her pregnancy. Shortly after she gave birth, her son, Maxwell, was admitted to the neonatal intensive care unit at Le Bonheur ...

Kolkata: A premature newborn girl, weighing only 720 g, underwent a cardiac procedure—that is usually considered for babies only after they have attained at least 5 kg weight—on the eighth day after ...